Bonraybio Co., Ltd. (TPE:6955)
Taiwan · Delayed Price · Currency is TWD 162.00
+2.50 (1.57%)
At close: Jan 21, 2026
Bonraybio Market Cap
Bonraybio has a market cap or net worth of 4.02 billion as of January 21, 2026. Its market cap has increased by 45.02% in one year.
Market Cap
4.02B
Enterprise Value
3.50B
Revenue
287.10M
Ranking
n/a
PE Ratio
41.31
Stock Price
162.00
Market Cap Chart
Since July 25, 2023, Bonraybio's market cap has increased from 1.48B to 4.02B, an increase of 172.16%. That is a compound annual growth rate of 49.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 4.02B | 9.46% |
| Dec 31, 2025 | 3.67B | 24.12% |
| Dec 31, 2024 | 2.96B | 101.25% |
| Dec 29, 2023 | 1.47B | -0.46% |
| Jul 25, 2023 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hi-Clearance | 6.08B |
| Delta Asia International | 6.05B |
| HCmed Innovations | 4.86B |
| Medimaging Integrated Solution | 3.38B |
| WeLeader Biomedical | 3.24B |
| InnoCare Optoelectronics | 2.79B |
| A Plus Biotechnology | 2.76B |
| Diamond Biotechnology | 2.62B |